A single-center experience of central nervous system tumors in children under three years old

被引:0
|
作者
Wang, Junhua [1 ,2 ]
Wang, Chuanwei [3 ]
Huang, Zhimin [1 ,2 ]
Zhang, Zhihua [1 ,2 ]
Zhang, Yuqi [1 ,2 ]
机构
[1] Tsinghua Univ, Tsinghua Univ Hosp Integrated Tradit Chinese & Wes, Yuquan Hosp, Dept Neurosurg, Beijing, Peoples R China
[2] Tsinghua Univ, Sch Clin Med, Beijing, Peoples R China
[3] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China
来源
FRONTIERS IN PEDIATRICS | 2024年 / 12卷
关键词
central nervous system; pediatrics; child; tumor; neurosurgery; chemotherapy; HIGH-DOSE CHEMOTHERAPY; STEM-CELL RESCUE; HEAD-START-I; BRAIN-TUMORS; MEDULLOBLASTOMA; AGE; SURVIVAL; OUTCOMES; RISK; RADIOTHERAPY;
D O I
10.3389/fped.2024.1441016
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose This study aims to summarize the characteristics of children under three years old (<= 3 years) with central nervous system (CNS) tumors and to investigate the factors that influence their overall survival (OS) time.Methods We treated 171 pediatric patients (<= 3 years) with CNS tumors at Yuquan Hospital of Tsinghua University from January 2016 to June 2023. Of these, 162 cases were successfully followed up. Kaplan-Meier survival analysis and Cox regression were utilized to evaluate factors potentially influencing OS of malignancies.Results There was a male predominance among the patients. The three most common tumors were embryonal tumors, gliomas, and craniopharyngiomas. Gross total resection (GTR) was achieved in select cases. Patients with high-grade malignancies were advised to undergo chemotherapy and/or radiotherapy after surgery. Optic gliomas and diffuse midline gliomas were partially resected and treated with adjuvant treatments. The median survival time of low-grade malignant tumors was 41.5 months, while that of high-grade malignant tumors was 15 months. Kaplan-Meier survival analysis identified the factors potentially influencing OS of malignancies: extent of resection, CNS WHO grade, grade of malignancies, and Ki-67 labeling index (Ki-67 LI). Subsequent multivariate analysis highlighted the interactive factor (extent of resection x CNS WHO grade) along with Ki-67 LI, as the most significant variables. Factors such as sex, age, tumor location, and onset-to-treatment time appeared not to affect OS.Conclusions GTR remains the cornerstone of treatment for children (<= 3 years) with CNS tumors, except for optic glioma, diffuse midline glioma, and germinoma. The interactive factor (extent of resection x CNS WHO grade) and Ki-67 LI are the most significant factors affecting OS. The implementation of preoperative neoadjuvant chemotherapy and early postoperative chemotherapy may enhance prognosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The retrospective analysis of central nervous system lymphomas: Single-center experience.
    Sunar, Veli
    Yasar, Arzu
    Sarici, Furkan
    Esin, Ece
    Diker, Omer
    Lacin, Sahin
    Turker, Alev
    Ozdemir, Evren
    Barista, Ibrahim
    Kars, Ayse
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] OUTCOME OF CENTRAL NERVOUS SYSTEM (CNS) PRIMITIVE NEUROECTODERMAL TUMORS (PNETS) IN CHILDREN: FIFTEEN YEARS EXPERIENCE FROM A SINGLE CENTER IN TURKEY
    Eker, N.
    Tayfun, F.
    Guler, E.
    Hazar, V.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 238 - 239
  • [23] Central nervous system tumors in patients under three years of age:: Treatment results of a single institute
    Varan, A
    Akalan, N
    Söylemezoglu, F
    Zorlu, F
    Yalçin, B
    Akyüz, C
    Kutluk, T
    Büyükpamukçu, M
    PEDIATRIC NEUROSURGERY, 2006, 42 (02) : 89 - 94
  • [24] Liver Grafts from Donors with Central Nervous System Tumors: A Single-Center Perspective
    Kashyap, Randeep
    Ryan, Charlotte
    Sharma, Rajeev
    Maloo, Manoj K.
    Safadjou, Saman
    Graham, Maureen
    Tretheway, David
    Jain, Ashokkumar
    Orloff, Mark
    LIVER TRANSPLANTATION, 2009, 15 (10) : 1204 - 1208
  • [25] CANCER PREDISPOSITION SYNDROME WITH PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: A SINGLE-CENTER STUDY
    Kubota, Hirohito
    Fukuoka, Kohei
    Oba, Daiju
    Mitani, Yuichi
    Mori, Makiko
    Oshima, Koichi
    Arakawa, Yuki
    Kurihara, Jun
    Ohashi, Hirofumi
    Koh, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S16 - S17
  • [26] Experience of the Management of Central Nervous System Tumors in Children Younger than 5 Years-Old in the Last 15 Years
    Garcia-Ariza, M.
    Lopez-Almaraz, R.
    Echebarria Barona, A.
    Adan Pedroso, R.
    Ojinaga Nino, I.
    Ricondo De Diego, A.
    Bilbao Salcines, N.
    Martinez Gonzalez, M. J.
    Garcia Rives, A.
    Valduvieco, I.
    Galbarriatu Gutierrez, L.
    de Gopegui Ruiz, E. Ruiz
    Zaldumbide Duenas, L.
    Martin Guerrero, I.
    Aurtenetxe Saez, O.
    Collazos Zabala, L.
    Navajas Gutierrez, A.
    Astigarraga Aguirre, I.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S304 - S304
  • [27] Central nervous system tuberculosis in non-HIV-positive children: a single-center, 6 year experience
    Delfino, L. Nogueira
    Fariello, G.
    Lancella, L.
    Marabotto, C.
    Menchini, L.
    Devito, R.
    Errante, Y.
    Quattrocchi, C. C.
    Longo, D.
    RADIOLOGIA MEDICA, 2012, 117 (04): : 669 - 678
  • [28] VERY YOUNG PATIENTS AND CENTRAL NERVOUS SYSTEM TUMORS: A SINGLE-CENTER EXPERIENCE IN AN UPPER-MIDDLE-INCOME COUNTRY
    Madrigal-Avila, Claudia
    Perez-Banuelos, Alfonso
    Perez-Garcia, Martin
    Ruvalcaba-Sanchez, Rafael
    Vega-Vega, Lourdes
    Escamilla-Asiain, Gabriela
    NEURO-ONCOLOGY, 2020, 22 : 386 - 386
  • [29] Characteristics of breast cancer patients with central nervous system metastases: A single-center experience
    Harputluoglu, Hakan
    Dizdar, Omer
    Aksoy, Sercan
    Kilickap, Saadettin
    Dede, Didem S.
    Ozisik, Yavuz
    Guler, Nilufer
    Barista, Ibrahim
    Gullu, Ibrahim
    Hayran, Mutlu
    Selek, Ugur
    Cengiz, Mustafa
    Zorlu, Faruk
    Tekuzman, Gulten
    Altundag, Kadri
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2008, 100 (05) : 521 - 526
  • [30] Nimotuzumab Therapy in Treatment of Paediatric Central Nervous System Tumors: Single Center Experience
    Akyuz, C.
    Varan, A.
    Bayhan, T.
    Aydin, B.
    Yalcin, B.
    Kurucu, N.
    Kalkan, N.
    Bajin, I.
    Babacan, A.
    Kutluk, T.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S129 - S129